FDA, Global Partners Prepare To Ramp Up Single-Audit Program
This article was originally published in The Gray Sheet
Executive Summary
FDA is strongly encouraging manufacturers to participate in the Medical Device Single Audit Program, set to launch in a pilot phase by June. An agency official points to strong global incentives, particularly for firms pursuing the Brazil and Canada markets.